Literature DB >> 27859598

Reduction of GAPDH in lenses of Parkinson's disease patients: A possible new biomarker.

Alexa Klettner1, Andreas Tholey2, Alena Wiegandt2, Elisabeth Richert1, Bernhard Nölle1, Günther Deuschl3, Johann Roider1, Susanne A Schneider3,4.   

Abstract

BACKGROUND: We previously showed that the protein pattern of lenses removed in cataract surgery differs between patients with Parkinson's disease and age-matched controls. In this study, we identified the protein reduced in abundance in the 34- to 37-kDa gel band.
METHODS: During cataract surgery (phacoemulsification), we collected the rinsing fluid and lens particles from the eyes of PD patients and controls. Residual lens fragments in the supernatant of 3 PD patients and aged-matched controls were studied for protein profiles using liquid chromatography-mass spectrometry and Western blots.
RESULTS: We identified glyceraldehyde-3-phosphate dehydrogenase by mass spectrometry as the protein reduced in abundance and verified this finding in Western blots.
CONCLUSIONS: Glyceraldehyde-3-phosphate dehydrogenase has been implicated in PD development. The reduction of glyceraldehyde-3-phosphate dehydrogenase in the lenses of PD patients may be a new biomarker for PD and might also indicate an important role for this protein in PD development.
© 2016 International Parkinson and Movement Disorder Society. © 2016 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  GAPDH; Parkinson's disease; cataract

Mesh:

Substances:

Year:  2016        PMID: 27859598     DOI: 10.1002/mds.26863

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  3 in total

1.  Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.

Authors:  Isabel Ortuño-Lizarán; Thomas G Beach; Geidy E Serrano; Douglas G Walker; Charles H Adler; Nicolás Cuenca
Journal:  Mov Disord       Date:  2018-05-08       Impact factor: 10.338

2.  Robust Ensemble Classification Methodology for I123-Ioflupane SPECT Images and Multiple Heterogeneous Biomarkers in the Diagnosis of Parkinson's Disease.

Authors:  Diego Castillo-Barnes; Javier Ramírez; Fermín Segovia; Francisco J Martínez-Murcia; Diego Salas-Gonzalez; Juan M Górriz
Journal:  Front Neuroinform       Date:  2018-08-14       Impact factor: 4.081

3.  A Dual, Systematic Approach to Malaria Diagnostic Biomarker Discovery.

Authors:  Seda Yerlikaya; Ewurama D A Owusu; Augustina Frimpong; Robert Kirk DeLisle; Xavier C Ding
Journal:  Clin Infect Dis       Date:  2022-01-07       Impact factor: 9.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.